Comparative Pharmacology
Head-to-head clinical analysis: PROMETH VC W CODEINE versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROMETH VC W CODEINE versus QOLIANA.
PROMETH VC W/ CODEINE vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promethazine is a phenothiazine derivative with antihistaminic, sedative, antiemetic, and anticholinergic effects. Codeine is an opioid agonist; its analgesic and antitussive effects are mediated via mu-opioid receptors.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
10 mL (5 mg codeine, 6.25 mg promethazine) orally every 4-6 hours as needed, not to exceed 60 mg codeine per day.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Codeine: terminal elimination half-life is 2.5-4 hours in adults. Promethazine: terminal elimination half-life is 9-16 hours, with a mean of 12 hours.
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Codeine and its metabolites are primarily excreted renally. Approximately 90% of a dose is excreted in the urine within 24 hours, with 10-15% as unchanged codeine, 40-60% as codeine-6-glucuronide, 5-15% as morphine, and 5-10% as norcodeine. Promethazine is extensively metabolized in the liver and excreted in urine and feces; about 70-80% appears in urine as metabolites and unchanged drug (less than 1% unchanged), with 20-30% in feces via biliary elimination.
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist